Inhibition of topoisomerase II by ICRF-193 prevents efficient replication of herpes simplex virus type 1.
Cellular topoisomerase II is specifically inactivated by the drug ICRF-193. This compound turns topoisomerase II into a closed clamp that is unable to cleave DNA. We have investigated the effects of this inhibitor on the replication of herpes simplex virus type 1. We show that ICRF-193 at low multip...
שמור ב:
| הוצא לאור ב: | J Virol |
|---|---|
| Principais autores: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1996
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC190388/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8676478/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.70.7.4523-4529.1996 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|